FedECA: Federated External Control Arms for Causal Inference with Time-To-Event Data in Distributed Settings
Jean Ogier du Terrail(Atkins (United States)), Mathieu Andreux(Unknown), Rémy Nicolle(Centre National de la Recherche Scientifique), Félix Balazard, Kawther Abdilleh(Pancreatic Cancer Action Network), Sudheer Doss(Pancreatic Cancer Action Network), J. Cros(Assistance Publique – Hôpitaux de Paris), Mohammad Hallal, Quentin Klopfenstein, Imke Mayer, Adelaida García Velasco(Institut Català d'Oncologia), Jean‐Baptiste Bachet(Sorbonne Université), Honghao Li(Beihang University), Daniel González(University of North Carolina at Chapel Hill), Robert Carreras‐Torres(Institut de Biologia Evolutiva), Pierre Laurent‐Puig(Inserm), Nicolas Loiseau, Shulin Zhao(Inserm), Zahia Yanes, Michael Debouver, Thibault Camalon, Thibault Fouqueray, Laëtitia Dahan, Jorge Arellano Castro, Julien Taı̈eb(Hôpital Européen Georges-Pompidou)
Cited by 1
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k